Literature DB >> 15560979

Bacterial ghosts--biological particles as delivery systems for antigens, nucleic acids and drugs.

Chakameh Azimpour Tabrizi1, Petra Walcher, Ulrike Beate Mayr, Thomas Stiedl, Matthias Binder, John McGrath, Werner Lubitz.   

Abstract

Despite the exponential rate of discovery of new antigens and DNA vaccines resulting from modern molecular biology and proteomics, the lack of effective delivery technology is a major limiting factor in their application. The bacterial ghost system represents a platform technology for antigen, nucleic acid and drug delivery. Bacterial ghosts have significant advantages over other engineered biological delivery particles, owing to their intrinsic cellular and tissue tropic abilities, ease of production and the fact that they can be stored and processed without the need for refrigeration. These particles have found both veterinary and medical applications for the vaccination and treatment of tumors and various infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15560979     DOI: 10.1016/j.copbio.2004.10.004

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  15 in total

1.  Protective efficacy by various doses of Salmonella ghost vaccine candidate carrying enterotoxigenic Escherichia coli fimbrial antigen against neonatal piglet colibacillosis.

Authors:  Jin Hur; John Hwa Lee
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

2.  A novel dual vector coexpressing PhiX174 lysis E gene and staphylococcal nuclease A gene on the basis of lambda promoter pR and pL, respectively.

Authors:  Lixia Fu; Chengping Lu
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

3.  Immunological characterization of the chemically prepared ghosts of Salmonella Typhimurium as a vaccine candidate.

Authors:  Sameh Rabea; Aymen S Yassin; Aly Fahmy Mohammed; Mounir M Salem-Bekhit; Fars K Alanazi; Eman Amin Esmail; Nayera A Moneib; Abd Elgawad M Hashem
Journal:  BMC Vet Res       Date:  2022-02-18       Impact factor: 2.741

Review 4.  Recent trends and advances in microbe-based drug delivery systems.

Authors:  Pravin Shende; Vasavi Basarkar
Journal:  Daru       Date:  2019-08-02       Impact factor: 3.117

5.  Attenuated Salmonella typhimurium delivering DNA vaccine encoding duck enteritis virus UL24 induced systemic and mucosal immune responses and conferred good protection against challenge.

Authors:  Xia Yu; Renyong Jia; Juan Huang; Bin Shu; Dekang Zhu; Qing Liu; Xinghong Gao; Meng Lin; Zhongqiong Yin; Mingshu Wang; Shun Chen; Yin Wang; Xiaoyue Chen; Anchun Cheng
Journal:  Vet Res       Date:  2012-07-06       Impact factor: 3.683

Review 6.  Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics.

Authors:  Aditya Ganeshpurkar; Ankit Ganeshpurkar; Vikas Pandey; Abhishek Agnihotri; Divya Bansal; Nazneen Dubey
Journal:  Int J Pharm Investig       Date:  2014-01

7.  Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge.

Authors:  Ulrike Beate Mayr; Pavol Kudela; Alena Atrasheuskaya; Eugenij Bukin; Georgy Ignatyev; Werner Lubitz
Journal:  Microb Biotechnol       Date:  2011-11-22       Impact factor: 5.813

8.  Effectiveness of F18+ Fimbrial Antigens Released by a Novel Autolyzed Salmonella Expression System as a Vaccine Candidate against Lethal F18+ STEC Infection.

Authors:  Gayeon Won; John H Lee
Journal:  Front Microbiol       Date:  2016-11-22       Impact factor: 5.640

9.  Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malaria.

Authors:  Elke S Bergmann-Leitner; Heather Hosie; Jessica Trichilo; Elizabeth Deriso; Ryan T Ranallo; Timothy Alefantis; Tatyana Savranskaya; Paul Grewal; Christian F Ockenhouse; Malabi M Venkatesan; Vito G Delvecchio; Evelina Angov
Journal:  Front Immunol       Date:  2013-07-04       Impact factor: 7.561

10.  Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers.

Authors:  Aleksandra Inic-Kanada; Marijana Stojanovic; Simone Schlacher; Elisabeth Stein; Sandra Belij-Rammerstorfer; Emilija Marinkovic; Ivana Lukic; Jacqueline Montanaro; Nadine Schuerer; Nora Bintner; Vesna Kovacevic-Jovanovic; Ognjen Krnjaja; Ulrike Beate Mayr; Werner Lubitz; Talin Barisani-Asenbauer
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.